WO1998001557A3 - Reactifs apparentes a des chemokines mammaliennes - Google Patents

Reactifs apparentes a des chemokines mammaliennes Download PDF

Info

Publication number
WO1998001557A3
WO1998001557A3 PCT/US1997/010819 US9710819W WO9801557A3 WO 1998001557 A3 WO1998001557 A3 WO 1998001557A3 US 9710819 W US9710819 W US 9710819W WO 9801557 A3 WO9801557 A3 WO 9801557A3
Authority
WO
WIPO (PCT)
Prior art keywords
reagents
mammalian chemokine
chemokine reagents
chemokines
mammalian
Prior art date
Application number
PCT/US1997/010819
Other languages
English (en)
Other versions
WO1998001557A2 (fr
Inventor
Kurt C Gish
Thomas J Schall
Alain Vicari
Albert Zlotnik
Wei Wang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to JP10505213A priority Critical patent/JP2000514295A/ja
Priority to EP97932238A priority patent/EP0909321A2/fr
Priority to AU35749/97A priority patent/AU3574997A/en
Publication of WO1998001557A2 publication Critical patent/WO1998001557A2/fr
Publication of WO1998001557A3 publication Critical patent/WO1998001557A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des chémokines mammaliennes, des réactifs apparentés à ces chémokines, y compris des protéines purifiées, des anticorps spécifiques et des acides nucléiques codant pour ces chémokines. L'invention concerne également des récepteurs de chémokines. L'invention concerne enfin des procédés d'utilisation de ces réactifs ainsi que des matériels de diagnostic.
PCT/US1997/010819 1996-07-05 1997-07-02 Reactifs apparentes a des chemokines mammaliennes WO1998001557A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10505213A JP2000514295A (ja) 1996-07-05 1997-07-02 哺乳動物のケモカイン試薬
EP97932238A EP0909321A2 (fr) 1996-07-05 1997-07-02 Reactifs apparentes a des chemokines mammaliennes
AU35749/97A AU3574997A (en) 1996-07-05 1997-07-02 Mammalian chemokine reagents

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US67581496A 1996-07-05 1996-07-05
US2832996P 1996-10-11 1996-10-11
US4859397P 1997-06-04 1997-06-04
US08/675,814 1997-06-04
US60/048,593 1997-06-04
US60/028,329 1997-06-04

Publications (2)

Publication Number Publication Date
WO1998001557A2 WO1998001557A2 (fr) 1998-01-15
WO1998001557A3 true WO1998001557A3 (fr) 1998-04-09

Family

ID=27363254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/010819 WO1998001557A2 (fr) 1996-07-05 1997-07-02 Reactifs apparentes a des chemokines mammaliennes

Country Status (4)

Country Link
EP (1) EP0909321A2 (fr)
JP (1) JP2000514295A (fr)
AU (1) AU3574997A (fr)
WO (1) WO1998001557A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133273B2 (en) 2010-11-19 2015-09-15 Eisai R&D Management Co., Ltd. Nucleic acids encoding neutralizing anti-CCL20 antibodies

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
WO1998021330A1 (fr) * 1996-11-15 1998-05-22 Indiana University Foundation Materiaux et procedes destines a la chemokine exodus
AU6871798A (en) * 1997-03-28 1998-10-22 Zymogenetics Inc. Human chemokine zsig-35
CA2287876A1 (fr) * 1997-04-30 1998-11-05 F. Hoffmann-La Roche Ag Chemokine st38.2 du rat
EP0974357A1 (fr) 1998-07-16 2000-01-26 Schering-Plough Chemokines comme adjuvants de la réponse immunitaire
AU5459599A (en) * 1998-08-17 2000-03-06 Schering Corporation Regulation of dendritic cell trafficking
US6645491B1 (en) 1999-02-03 2003-11-11 Schering Corporation Method for treating inflammatory conditions using an antibody to MIP-3α
CA2362091A1 (fr) * 1999-02-03 2000-08-10 Schering Corporation Utilisation d'agonistes ou d'antagonistes de la chimiokine mip-3a a des fins therapeutiques
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
WO2001017558A2 (fr) * 1999-09-08 2001-03-15 Schering Corporation Nouvelles utilisations des recepteurs ccr6 de mammiferes et reactifs associes
CA2460321A1 (fr) * 2001-09-20 2003-03-27 Schering Corporation Chimiokines en tant qu'agents auxiliaires de reponse immunitaire
US7375192B2 (en) 2002-05-01 2008-05-20 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
WO2005057220A2 (fr) * 2003-12-05 2005-06-23 Oxagen Limited Ligands
DK1809660T3 (da) * 2004-10-25 2014-10-20 Immune System Key Ltd Thymus-specifikt protein
WO2007122622A1 (fr) * 2006-04-24 2007-11-01 Immune System Key Ltd. Méthode de traitement d'une maladie

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005856A1 (fr) * 1994-08-23 1996-02-29 Human Genome Sciences, Inc. Polypeptides de type chemokine humaine
WO1996016979A1 (fr) * 1994-11-29 1996-06-06 Incyte Pharmaceuticals, Inc. Production et utilisation des chimiokines exprimees
WO1996022374A1 (fr) * 1995-01-19 1996-07-25 Incyte Pharmaceuticals, Inc. Nouvelle chemoquine exprimee dans la rate de foetus, son mode de production et ses utilisations
WO1996024668A1 (fr) * 1995-02-08 1996-08-15 Human Genome Sciences, Inc. Chemokine humaine beta-11 et chemokine humaine alpha-1

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005856A1 (fr) * 1994-08-23 1996-02-29 Human Genome Sciences, Inc. Polypeptides de type chemokine humaine
WO1996016979A1 (fr) * 1994-11-29 1996-06-06 Incyte Pharmaceuticals, Inc. Production et utilisation des chimiokines exprimees
WO1996022374A1 (fr) * 1995-01-19 1996-07-25 Incyte Pharmaceuticals, Inc. Nouvelle chemoquine exprimee dans la rate de foetus, son mode de production et ses utilisations
WO1996024668A1 (fr) * 1995-02-08 1996-08-15 Human Genome Sciences, Inc. Chemokine humaine beta-11 et chemokine humaine alpha-1

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
A. P. VICARI ET AL: "TECK: a novel CC chemokine associated with T-cell development", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 99, no. 1 part 2, January 1997 (1997-01-01), pages S246, XP002048195 *
A. ZABALLOS ET AL: "Molecular cloning and RNA expression of two new human chemokine receptor-like genes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS., vol. 227, no. 3, 23 October 1996 (1996-10-23), ORLANDO, FL US, pages 846 - 853, XP002055490 *
A.P. VICARI ET AL: "TECK: A novel CC chemokine Specifically expressed by thymic dendritic cells and potentially involved in T cell development", IMMUNITY, vol. 7, August 1997 (1997-08-01), pages 291 - 301, XP002048197 *
C. NGUYEN ET AL: "MTA.F02.091 5'. a MTA adult mouse thymus library Mus musculus cDNA clone MTA.F02.091 5'end", EMBL DATABASE ENTRY MMW91616 ; ACCESSION NUMBER'91616, 10 July 1996 (1996-07-10), XP002048196 *
D.L.ROSSI ET AL: "Identification through bioinformatics of two new macrophage proinflammatory human chemokines", JOURNAL OF IMMUNOLOGY., vol. 158, no. 3, 1 February 1997 (1997-02-01), BALTIMORE US, pages 1033 - 1036, XP002055486 *
KUNIO HIESHIMA ET AL: "Molecular cloning of a novel CC Chemokine liver and activation-regulated chemokine (LARC) expressed in liver", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 272, no. 9, 28 February 1997 (1997-02-28), MD US, pages 5846 - 5853, XP002055489 *
L. HILLIER ET AL: "The WashU-Merck EST project;za74f04.s1 Homo sapiens cDNA clone 298303 3'", EMBL DATABASE ENTRY HS958307, ACCESSION NUMBER N73958, 23 March 1996 (1996-03-23), XP002048193 *
L. HILLIER ET AL: "za81g11.r1 Soares fetal lung NbHL19W Homo sapiens cDNA clone 299012 5'", EMBL DATABASE ENTRY HS519338, ACCESSION NUMBER W05519, 8 May 1996 (1996-05-08), XP002055484 *
MASATAKA BABA ET AL: "Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 272, no. 23, 6 June 1997 (1997-06-06), MD US, pages 14893 - 14898, XP002055488 *
OSAMU YOSHIE ET AL: "Novel lymphocyte-specific CC chemokines and their receptors", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 62, no. 5, November 1997 (1997-11-01), pages 634 - 644, XP002055491 *
RYU YOSHIDA ET AL: "molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 272, no. 21, 23 May 1997 (1997-05-23), MD US, pages 13803 - 13809, XP002055487 *
T.I. BONNER ET AL: "Cloning, tissue distribution and chromosomal localization of a potential G-protein-linked receptor", EMBL DATABASE ENTRY HS459841, ACCESSION NUMBER U45984, 5 April 1996 (1996-04-05), XP002055485 *
T.J. SCHALL ET AL: "Chemokines, Leukocyte trafficking, and inflammation", CURRENT OPINION IN IMMUNOLOGY, vol. 6, no. 6, December 1994 (1994-12-01), pages 865 - 873, XP002048194 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133273B2 (en) 2010-11-19 2015-09-15 Eisai R&D Management Co., Ltd. Nucleic acids encoding neutralizing anti-CCL20 antibodies

Also Published As

Publication number Publication date
WO1998001557A2 (fr) 1998-01-15
JP2000514295A (ja) 2000-10-31
AU3574997A (en) 1998-02-02
EP0909321A2 (fr) 1999-04-21

Similar Documents

Publication Publication Date Title
WO1997021812A3 (fr) Chemokine mammifere ccf8 et recepteur de chemokine cckr3
WO1998001557A3 (fr) Reactifs apparentes a des chemokines mammaliennes
EP2100959A3 (fr) Cytokine de mammifères: interleukine-B30 et réactifs apparentés
WO1998027114A3 (fr) Antigenes de surface mammaliens et reactifs associes
CA2263129A1 (fr) Antigenes de surface de cellules mammaliennes et reactifs qui y sont lies
WO1995018826A3 (fr) Antigenes a ctla-8 de primates purifiee et reactifs correspondants
WO2000042188A3 (fr) Cytokines de mammiferes liees a l'interleukin-17, polynucleotides les codant et leurs utilisations
EP1114864A3 (fr) Antigènes de surface de cellules de mammifères
WO1998011226A3 (fr) Chemokines de mammiferes et reactifs apparentes
WO1998024906A3 (fr) Genes isoles de monocytes de mammifere et reactifs associes
EP1980573A3 (fr) Gènes de protéine de membrane cellulaire dendritique isolée
EP1897949A3 (fr) Utilisations thérapeutiques d'interleukine-B50 humaine
EP1942114A3 (fr) "Cytokines de mammifères ; réactifs et procédés associés"
WO1998032858A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, et modes d'utilisation
AU1825097A (en) Mammalian cx3c chemokine genes
WO1998023750A3 (fr) Chemokines de mammiferes
WO1998039421A3 (fr) Proteinase mammaliennes, oxydoreductase, proteines de liaison avec gtp et reactifs correspondants
WO1998031810A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, utilisations
AU1695595A (en) Mammalian thymokine genes
WO1999047673A3 (fr) Genes de proteines membranaires mammiferes isoles, et reactifs associes
EP0997476A3 (fr) Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
WO2001009176A3 (fr) Cytokines mammaliennes; reactifs correspondants
WO2000034335A3 (fr) Genes mammiferes et reactifs connexes
WO1998023747A3 (fr) Genes isoles de cellules dendritiques de mammiferes et reactifs correspondants
WO1999019491A3 (fr) Interleukine-40 adnx humaine (dil-40)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GE HU IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GE HU IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 505213

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997932238

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997932238

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997932238

Country of ref document: EP